QUIBIM
Taking part in the EU’s H2020 initiative translated into huge strides in disease detection and diagnosis by QUIBIM, by enabling the development of tools powered…
QUIBIM is helping to advance knowledge of the most lethal pediatric tumors through EU-funded program PRIMAGE, which exploits precision information from medical imaging to establish…
Pain, depression, slurred speech and feeling of numbness, tingling, or weakness. These are just some symptoms of Multiple Sclerosis (MS) disease, a long-term condition that…
Chest X-ray classifier is added as a new CE cleared tool within QUIBIM Precision platform, which already received CE mark class IIa certification earlier in…
We are proud to announce the incorporation of two new Quibimers in our growing team. Both excellent computer scientists, passionate about practising sport and named…
We are very happy to share with you QUIBIM´s experience at the last Outsourcing in Clinical Trials Europe 2019 from 14th to 15th of May in…